Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Withdrawn
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT07060365 |
| Recruiting Status | Withdrawn |
| Condition | Ovarian Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 8 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | February 20, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT07060365 is currently withdrawn participants. This clinical trial study for ovarian cancer is not currently accepting new participants at 8 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT07060365 is currently withdrawn. The study may resume recruiting in the future.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07060365 was last updated 1 week ago (February 20, 2026). HelloStudys verifies this status automatically.